Does lorundrostat reduce 24-hour average blood pressure in participants with uncontrolled and treatment-resistant hypertension?
Lorundrostat effectively reduces 24-hour average blood pressure in patients with uncontrolled and treatment-resistant hypertension.
Lorundrostat was associated with greater reductions in 24-hour average blood pressure than placebo in participants with uncontrolled and treatment-resistant hypertension. (Funded by Mineralys Therapeutics; Advance-HTN ClinicalTrials.gov number, NCT05769608.).
Laffin et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: